A PE-backed medical technology company in Oxford specialising in organ preservation has completed a $142m primary and secondary equity financing.

Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it will effect a 1-for-11 reverse stock split of the Company’s ...